EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinib

Steffan T Nawrocki, Claudia M Espitia, Maria Janina Carrera Espinoza, Trace M Jones, Madison E Gamble, Sruthi Sureshkumar, Mengyang Chang, Wei Wang, Jennifer S Carew iD

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.1662 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Steffan T Nawrocki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology and Oncology, University of Arizona Cancer Center, Tucson, Arizona, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Lapatinib, Autophagy, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinibDear Editor, Brain metastases are the most prevalent adult central nervous system tumours with 20%-30% of cases resulting from breast cancer patients, particularly those with triple-negative (ER-, PR-, HER2 unamplified) and HER2 amplified disease.The prognosis for individuals with brain metastases from breast cancer continues to be extremely unfavourable, with a mere 20% achieving 5-year survival.1 New targeted approaches are clearly needed to improve outcomes for this patient population.Autophagy is a lysosomal catabolic process that controls the turnover of organelles and selected proteins.2,3 During metastogenesis, tumour cells face diverse stressors including nutrient and oxygen deprivation and may activate autophagy to avert bioenergetic failure and sustain their survival.4 We investigated the role of autophagy competence as a regulator of the brain metastogenic potential of breast cancer cells and assessed inhibition of autophagy as a clinically actionable approach to prevent and treat brain metastases.We first used the well characterized breast cancer cell line MDA-MB-231 and its brain-targeted metastatic variants (231-BR and 231-BR-HER2) to investigate differences in energy metabolism in cells that preferentially metastasize to the brain (Figure S1A,B).[5][6][7] Global metabolic profiling identified the nucleotide biosynthesis super pathway as one of the most significantly altered between parental and brain metastatic breast cancer cells (Figure 1A,B).Quantification of individual nucleotide pathway components revealed that adenosine 5′-monophosphate (AMP) and adenosine 5′-disphosphate (ADP_ levels were remarkably higher, while ATP levels were significantly lower in the brain metastatic variants (Figure 1C).Notably, differences in ATP production between other types of primary tumours and metastases were also recently reported.8 We detected diminished levels of the TCA cycle intermediates citrate, cis-aconitate, and malate (Figure S2), lower pyrophosphate and higher phosphate levels (Figure S3),

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLapatinibAutophagyAntineoplastic AgentsHumansFemaleBrain Neoplasms

Substanzen

LapatinibAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Medicine, Division of Hematology and Oncology, University of Arizona Cancer Center, Tucson, Arizona, USA.
  • Department of Urology, University of Arizona, Tucson, Arizona, USA.
  • Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona, USA.
  • Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, USA.
  • Arizona Center for Drug Discovery, University of Arizona, Tucson, Arizona, USA.

ORCID-Profile: Jennifer S Carew

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Nawrocki, S. T., Espitia, C. M., Espinoza, M. J. C., Jones, T. M., Gamble, M. E., Sureshkumar, S., Chang, M., Wang, W., & Carew, J. S. (2024). Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinib. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1662

Vancouver

Nawrocki ST, Espitia CM, Espinoza MJC, Jones TM, Gamble ME, Sureshkumar S, et al. Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinib. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1662

BibTeX
@article{Nawrocki2024,
  author = {Nawrocki, Steffan T and Espitia, Claudia M and Espinoza, Maria Janina Carrera and Jones, Trace M and Gamble, Madison E and Sureshkumar, Sruthi and Chang, Mengyang and Wang, Wei and Carew, Jennifer S},
  title = {Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinib},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.1662}
}
Kostenlos starten →